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d  the  blind  pleural  biopsy  revealed  nonspeciﬁc  pleuri-
.  Due  to  symptomatic  persistence  and  pleural  thickening
using  pulmonary  restriction,  she  underwent  pulmonary
cortication  and  parietal  pleurectomy.  Pleural  histologi-
l  examination  revealed  epithelioid  cells  proliferation  with
pia  and  positive  for  the  CD34  marker,  favoring  the  diag-
sis  of  epithelioid  hemangioendothelioma  (Fig.  1D).  The
raco--abdominal--pelvic  CT  did  not  show  other  alter-
ons.  Chemotherapy  was  initiated  with  Doxorubicin  but  the
tient  died  after  the  ﬁrst  cycle,  6  months  after  admission.
Primary  thoracic  sarcomas  are  tumors  derived  from
senchymal  cells,  they  represent  5%  of  all  thoracic  neo-
sms  and  may  involve  lung,  pleura  and  mediastinum.2
e  leiomyosarcoma  and  epithelioid  hemangioendothelioma
uniformly.4 Compared  to  the  pulmonary  form,  the  pleural
epithelioid  hemangioendothelioma  usually  has  an  aggressive
clinical  course  and  a  poor  prognosis.5,7 The  authors  describe
two  patients  with  rare  causes  of  pleural  effusion,  illustra-
tive  of  the  diagnostic  difﬁculty  and  aggressiveness  of  these
tumors.
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meth  pleuropulmonary  origin  are  two  extremely  rare  types
these  tumors  that,  due  to  the  clinical  and  histological
ilarity  to  other  pleural  neoplasms,  are  often  difﬁcult
diagnose,  with  most  of  the  cases  diagnosed  by  surgi-
l  biopsy.3,4 The  pleuropulmonary  leiomyosarcoma  usually
sents  as  a  nonspeciﬁc  pleural  mass  and/or  effusion
th  pulmonary  involvement  as  a  well  deﬁned  nodule  with
ooth  margins,  necrotic  mass  or  endobronchial  lesions.2,3
me  risk  factors  have  been  identiﬁed,  namely  previous
emotherapy  or  radiation  therapy  and  environmental  or
cupational  exposure.2 It  is  characterized  by  malignant
indle  cells  with  immunohistochemical  staining  for  smooth
scle  actin,  vimentin  and  desmin.2,3 The  treatment  of
oice  in  the  limited  disease  is  surgical  resection  asso-
ted  with  chemotherapy  and/or  radiation  assessed  on
case-by-case  basis,  depending  on  the  histological  grade
d  the  clinical  stage.2,3 In  the  advanced  disease  only
emotherapy  is  recommended.3 The  median  survival  for
tients  with  extensive  disease  is  about  12  months.3 The
ural  epithelioid  hemangioendothelioma  has  vascular  ori-
 and  usually  is  manifested  by  unilateral  pleural  effusion
d  nodular  pleural  thickening.4,5 The  clinical  presentation
variable,  however,  chest  pain,  dyspnea  and  cough  are
nsistent  symptoms.4 Although  risk  factors  are  unclear,
ses  have  been  described  that  follow  exposure  to  occu-
tional  contaminants,  such  as  rooﬁng  material,  industrial
posures,  cheese  making,  and  asbestos.6 It  is  charac-
ized  by  cords  and  nests  of  epithelioid  cells  similar  to
dothelial  cells,  associated  with  a  myxohyaline  matrix
d  immunoreactive  for  CD34,  CD31,  vimentin  and  fac-
 VIII.2,4 Surgical  resection  is  recommended  but,  when
practicable,  chemotherapy  has  been  used,  although  not
PD and physical activity
the  general  population,  the  beneﬁts  of  physical  activity
)  are  well  documented,  and  include  primary  prevention
d  control  of  many  chronic  diseases,  such  as  metabolic
cardiovascular  disease.  Being  physically  active  preserves
ne  mass  and  muscle  strength,  promotes  well-being,  cog-
ive  function  and  quality  of  life.  The  American  College
Sports  Medicine  states  that  healthy  adults  aged  18--65
ars1 need  a  minimum  of  30  min  of  moderate  aerobic  exer-
e  per  day,  ﬁve  days  a  week,  and  the  British  Association
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Sport  and  Exercise  Sciences  advises  at  least  150  min  of
derate-intensity  aerobic  activity  each  week,  or  75  min
vigorous-intensity  aerobic  activity  per  week.2 Adults  not
eting  these  values  should  be  considered  as  insufﬁciently
3tive.  However,  according  to  GOLD  guidelines, PA  is  rec-
mended  for  all  patients  with  COPD  just  because  it  seems
uitively  correct,  given  the  overall  population  beneﬁts,
t  without  COPD-speciﬁc  evidence  to  support  any  recom-
ndations.  On  the  other  hand,  pulmonary  rehabilitation
)  has  been  carefully  evaluated:  it  improves  exercise
pacity,  recovery  after  hospitalization  and  reduces  the
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exacerbations  requiring  hospitalizations.  The  2015  American
College  of  Chest  Physicians  and  Canadian  Thoracic  Soci-
ety  Guideline,4 the  ALAT  --  2014  COPD  Clinical  Practice
Guidelines,5 and  many  other  papers,  do  not  include  any
recommendations  regarding  physical  activity  in  COPD.  How-
ever,  for  primary  prevention,  treatment  and  control  of  many
other  diseases,  such  as  cardiovascular  diseases  or  hyperten-
sion,  recommendations  have  been  developed,  taking  into
account  the  physical  exercise  requirements  in  relation  to
duration,  frequency  and  intensity.  For  COPD  patients  there
is  an  emerging  need  not  only  for  recommendations,  but
for  practical  interventions  that  would  increase  physical
activity  which,  combined  with  smoking  cessation  and  phar-
macological  treatment,  could  prevent  disease  progression,
comorbidities  and  exacerbations.
Physical  inactivity  is  a  central  problem  in  COPD  patients
and  plays  a  crucial  role  in  the  development  of  COPD  comor-
bidities.  Being  physically  active  is  associated  with  a  reduced
risk  of  hospital  admission  and  mortality,6 and  this  is  the
best  available  evidence,  although  moderate,  concerning  PA
and  COPD.  More  low-intensity  physical  activity  reduces  the
risk  of  hospitalization,  but  daily  high-intensity  PA  does  not
generate  additional  beneﬁts.7 Because  of  the  increased
exertional  dyspnea  due  to  pulmonary  function  and  gas
exchange  abnormalities,  the  patients  decrease  their  phys-
ical  activity,  and  deconditioning  and  muscle  weakness  are
physiological  consequences.  Patients  with  severe  and  very
severe  COPD  carry  out  their  daily  activities  in  fewer  and
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patients  with  COPD.14 A  ﬁnal  problem  is  the  lack  of  knowl-
edge  about  the  daily  PA  in  the  real  life  of  stable  COPD
patients,  and  the  lack  of  knowledge  about  the  best  tools  for
PA  assessment:  self-report,  like  the  Minnesota  Leisure  Time
Physical  Activity  Questionnaire,  or  objective  measures,  such
as  the  use  of  a  pedometer  or  accelerometry-based  motion
sensor.
Pulmonary  rehabilitation  (PR)  is  regarded  as  one  of  the
most  effective  non-pharmacological  treatments  in  COPD
patients,15 with  clear  beneﬁts  in  the  pre/post-exacerbation
setting,  but  acceptance  and  uptake  of  pulmonary  rehabili-
tation  following  an  acute  exacerbation  are  very  poor,  and
many  patients  refuse  referral  to  post-acute  exacerbation
PR  because  of  practical  or  psychosocial  barriers.16 Instead,
regular  PA  is  available  to  all  patients.  Physical  activity,
objectively  measured,17 is  the  best  predictor  of  all-cause
mortality  in  patients  with  COPD,  with  a  linear  association
between  PA  and  mortality.  As  a  predictor  of  mortality,  PA
is  better  than  BODE  or  ADO  indexes,  malnutrition,  mus-
cle  wasting,  healthy  status,  cardiac  function,  depressive
symptoms  or  dyspnea.  Physical  Activity,  outside  a  pulmonary
rehabilitation  program,  such  as  domestic,  occupational  and
everyday  activities  for  independent  living,  and  physical
exercise,  inside  and  outside  their  homes,  in  light,  moderate
or  vigorous  intensity,  can,  together  with  smoking  cessation,
become  the  best  way  of  preventing  disease  progression,
comorbidities  and  exacerbations  of  COPD.  We  need  phar-
macological  and  nonpharmacological  strategies  to  overcome
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e.shorter  bouts  than  those  in  mild  and  moderate  stages.8 How
ever,  PA  is  a  multidimensional  issue  and  it  is  the  result  of
complex  interaction  of  many  factors,  such  as  socioeconom
status,  more  or  less  sedentary  occupation  or  patients  livin
alone  or  with  family  members.9
A  sedentary  lifestyle  is  present  in  all  stages  of  seve
ity  of  COPD.  Decreased  PA  is  already  present  in  the  ear
stages  of  the  disease  development,  and  worsens  as  the  di
ease  severity  progresses.  Many  patients  with  COPD  (30%)  d
not  achieve  30  min  of  walking  time  per  day,  and  are  effe
tively  housebound.  They  not  only  walk  for  less  time  per  da
but  they  also  walk  25%  slower  than  healthy  people,  and  the
spend  12%  of  the  day-time  lying  down,  compared  to  4%  fo
healthy  elderly  people.10 But  COPD  patients  are  capable  o
bouts  of  moderate-to-vigorous  physical  activity.  The  declin
in  PA  level  is  associated  with  increasing  airﬂow  limitation
but  it  is  not  signiﬁcantly  associated  with  changes  in  exercis
capacity:  avoiding  activities  is  a  strategy  for  avoiding  symp
toms.  These  two  observations  make  the  improvement  of  P
feasible  in  clinical  practice.
Patients  with  COPD  are  less  physically  active  than  health
subjects,  but  it  is  unclear  which  are  the  determinan
and  outcomes  of  this  reduced  activity.11 Comorbidities  con
tribute  to  impaired  functional  exercise  capacity,12 but  w
were  not  able  to  establish  age,  socioeconomic  or  cultur
status,  dyspnea,  FEV1  or  BMI  as  determinants  of  reduced
activity,  nor  dyspnea,  FEV1,  exercise  capacity  or  exacerba-
tions  as  outcomes  of  reduced  activity.  The  second  question
is  how  much  physical  activity  is  needed  to  obtain  health  ben-
eﬁts  in  sedentary  patients  with  COPD,  but  individualized
physical  activity  recommendations  will  probably  be  more
suitable  for  these  patients,  adapting  the  intensity  to  the
patient’s  aerobic  ﬁtness  level.13 A  third  question,  and  chal-
lenging  one,  is  whether  the  decline  in  PA  can  be  reversed  in
ethe  difﬁculties  in  the  implementation  of  regular  physic
activity,  but  improving  the  patient’s  self-management  edu
cation  and  the  relationship  of  trust  between  the  patient  an
the  physician18 may  be  the  most  important  of  all.
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